CHES1/FOXN3 Regulates Cell Proliferation by Repressing PIM2 and Protein Biosynthesis

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2014 Jan 10

PMID 24403608

Citations 21

Authors

Genevieve Huot

Mathieu Vernier

Veronique Bourdeau

Laurent Doucet

Emmanuelle Saint-Germain

Marie-France Gaumont-Leclerc

Alejandro Moro

Gerardo Ferbeyre

Affiliations

Soon will be listed here.

Abstract

The expression of the forkhead transcription factor checkpoint suppressor 1 (CHES1), also known as FOXN3, is reduced in many types of cancers. We show here that CHES1 decreases protein synthesis and cell proliferation in tumor cell lines but not in normal fibroblasts. Conversely, short hairpin RNA-mediated depletion of CHES1 increases tumor cell proliferation. Growth suppression depends on the CHES1 forkhead DNA-binding domain and correlates with the nuclear localization of CHES1. CHES1 represses the expression of multiple genes, including the kinases PIM2 and DYRK3, which regulate protein biosynthesis, and a number of genes in cilium biogenesis. CHES1 binds directly to the promoter of PIM2, and in cells expressing CHES1 the levels of PIM2 are reduced, as well as the phosphorylation of the PIM2 target 4EBP1. Overexpression of PIM2 or eIF4E partially reverses the antiproliferative effect of CHES1, indicating that PIM2 and protein biosynthesis are important targets of the antiproliferative effect of CHES1. In several human hematopoietic cancers, CHES1 and PIM2 expressions are inversely correlated, suggesting that repression of PIM2 by CHES1 is clinically relevant.

Citing Articles

The nuclear GYF protein CD2BP2/U5-52K is required for T cell homeostasis.

Bertazzon M, Hurtado-Pico A, Plaza-Sirvent C, Schuster M, Preussner M, Kuropka B Front Immunol. 2024; 15:1415839.

PMID: 39308865 PMC: 11412891. DOI: 10.3389/fimmu.2024.1415839.

Characterizing the tumor suppressor activity of FLCN in Birt-Hogg-Dubé syndrome through transcriptiomic and proteomic analysis.

Tee A, Jones R, Dunlop E, Champion J, Doubleday P, Claessens T Res Sq. 2024; .

PMID: 38978568 PMC: 11230511. DOI: 10.21203/rs.3.rs-4510670/v1.

FOXN3 inhibits the progression of ovarian cancer through negatively regulating the expression of RPS15A.

Yang H, Li M, Qi Y Hum Cell. 2023; 36(3):1120-1134.

PMID: 37016167 DOI: 10.1007/s13577-023-00876-9.

p38-mediated FOXN3 phosphorylation modulates lung inflammation and injury through the NF-κB signaling pathway.

Zhu X, Huang B, Zhao F, Lian J, He L, Zhang Y Nucleic Acids Res. 2023; 51(5):2195-2214.

PMID: 36794705 PMC: 10018351. DOI: 10.1093/nar/gkad057.

Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib.

Feriotto G, Marchetti P, Rondanin R, Tagliati F, Aguzzi S, Beninati S Int J Mol Sci. 2023; 24(3).

PMID: 36768681 PMC: 9916957. DOI: 10.3390/ijms24032356.

References

Markowski J, Tyszkiewicz T, Jarzab M, Oczko-Wojciechowska M, Gierek T, Witkowska M . Metal-proteinase ADAM12, kinesin 14 and checkpoint suppressor 1 as new molecular markers of laryngeal carcinoma. Eur Arch Otorhinolaryngol. 2009; 266(10):1501-7. DOI: 10.1007/s00405-009-1019-3. View

Pehlivan D, Gunduz E, Gunduz M, Nagatsuka H, Beder L, Cengiz B . Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol. 2008; 134(12):1267-76. DOI: 10.1007/s00432-008-0423-1. View

Wendel H, de Stanchina E, Fridman J, Malina A, Ray S, Kogan S . Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature. 2004; 428(6980):332-7. DOI: 10.1038/nature02369. View

Weinberg R . The retinoblastoma protein and cell cycle control. Cell. 1995; 81(3):323-30. DOI: 10.1016/0092-8674(95)90385-2. View

Basso K, Margolin A, Stolovitzky G, Klein U, Dalla-Favera R, Califano A . Reverse engineering of regulatory networks in human B cells. Nat Genet. 2005; 37(4):382-90. DOI: 10.1038/ng1532. View

Dai H, Li R, Wheeler T, De Vivar A, Frolov A, Tahir S . Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate. 2005; 65(3):276-86. DOI: 10.1002/pros.20294. View

Schuff M, Rossner A, Wacker S, Donow C, Gessert S, Knochel W . FoxN3 is required for craniofacial and eye development of Xenopus laevis. Dev Dyn. 2006; 236(1):226-39. DOI: 10.1002/dvdy.21007. View

Hammerman P, Fox C, Birnbaum M, Thompson C . Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood. 2005; 105(11):4477-83. PMC: 1895036. DOI: 10.1182/blood-2004-09-3706. View

Teng T, Mercer C, Hexley P, Thomas G, Fumagalli S . Loss of tumor suppressor RPL5/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity. Mol Cell Biol. 2013; 33(23):4660-71. PMC: 3838008. DOI: 10.1128/MCB.01174-13. View

10.

Wippich F, Bodenmiller B, Gustafsson Trajkovska M, Wanka S, Aebersold R, Pelkmans L . Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling. Cell. 2013; 152(4):791-805. DOI: 10.1016/j.cell.2013.01.033. View

11.

Scott K, Plon S . CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor. Gene. 2005; 359:119-26. DOI: 10.1016/j.gene.2005.06.014. View

12.

Calabrese V, Mallette F, Deschenes-Simard X, Ramanathan S, Gagnon J, Moores A . SOCS1 links cytokine signaling to p53 and senescence. Mol Cell. 2009; 36(5):754-67. DOI: 10.1016/j.molcel.2009.09.044. View

13.

Bouchard C, Marquardt J, Bras A, Medema R, Eilers M . Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J. 2004; 23(14):2830-40. PMC: 514943. DOI: 10.1038/sj.emboj.7600279. View

14.

Vernier M, Bourdeau V, Gaumont-Leclerc M, Moiseeva O, Begin V, Saad F . Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev. 2011; 25(1):41-50. PMC: 3012935. DOI: 10.1101/gad.1975111. View

15.

Paddison P, Cleary M, Silva J, Chang K, Sheth N, Sachidanandam R . Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat Methods. 2005; 1(2):163-7. DOI: 10.1038/nmeth1104-163. View

16.

Hu M, Lee D, Xia W, Golfman L, Ou-Yang F, Yang J . IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell. 2004; 117(2):225-37. DOI: 10.1016/s0092-8674(04)00302-2. View

17.

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

18.

Harvey K, Mattila J, Sofer A, Bennett F, Ramsey M, Ellisen L . FOXO-regulated transcription restricts overgrowth of Tsc mutant organs. J Cell Biol. 2008; 180(4):691-6. PMC: 2265581. DOI: 10.1083/jcb.200710100. View

19.

Markowski J, Oczko-Wojciechowska M, Gierek T, Jarzab M, Paluch J, Kowalska M . Gene expression profile analysis in laryngeal cancer by high-density oligonucleotide microarrays. J Physiol Pharmacol. 2009; 60 Suppl 1:57-63. View

20.

Schatz J, Oricchio E, Wolfe A, Jiang M, Linkov I, Maragulia J . Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma. J Exp Med. 2011; 208(9):1799-807. PMC: 3171093. DOI: 10.1084/jem.20110846. View